Several new drugs for the treatment of three types of cancer have been approved for inclusion in the National Health Insurance (NHI) program, which is expected to reduce the financial burden on some 1,000 patients per year and increase their life expectancy, Taiwan's government said Tuesday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Politics
Senior KMT official detained in Pingtung recall forgery case
07/02/2025 02:01 PM - Business
Taiwan shares close up 0.11%
07/02/2025 01:54 PM - Business
Stock trading accounts hit new high despite U.S. tariff concerns
07/02/2025 12:47 PM - Cross-Strait
Taiwan intelligence agency warns of RedNote, TikTok data breaches
07/02/2025 11:58 AM - Business
TSMC Arizona chairman to retire; no successor named yet
07/02/2025 11:12 AM